Persistent expression of a soluble form of Fas/APO1 in continuously activated T cells from a patient with SLE.

Autor: Kovacs B; Department of Clinical Physiology, Walter Reed Army Institute of Research, Washington, DC 20307-5100, USA., Szentendrei T, Bednarek JM, Pierson MC, Mountz JD, Vogelgesang SA, Tsokos GC

Publikováno v: Clinical and experimental rheumatology [Clin Exp Rheumatol] 1997 Jan-Feb; Vol. 15 (1), pp. 19-23.

Effects of IL-1 and cortisol on beta-adrenergic receptors, cell proliferation, and differentiation in cultured human A549 lung tumor cells.

Autor: Nakane T; Laboratory of Physiologic and Pharmacologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892., Szentendrei T, Stern L, Virmani M, Seely J, Kunos G

Publikováno v: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 1990 Jul 01; Vol. 145 (1), pp. 260-6.

Changes of GTP binding in hormone induced opiate or adrenergic sub sensitivity.

Autor: Fekete MI; EGIS Pharmaceuticals, Inst. Exp. Med., Hung. Acad. Sci., Budapest., Szentendrei T, Kiem DT

Publikováno v: Acta physiologica Hungarica [Acta Physiol Hung] 1990; Vol. 75 Suppl, pp. 103-4.

A view on the problem of providing oncological aid during the war in Ukraine.

Autor: Gordiichuk, Prokip^1,2 P_Gordijchuk@ukr.net, Kliusov, Oleksandr², Gordiichuk, Mykola^1,2, Kondratenko, Andrii², Ponomarova, Olga^1,2, Grushynska, Tamara², Kliusov, Artem², Chervynskyy, Ivan¹

Publikováno v: Contemporary Oncology / Współczesna Onkologia. 2022, Vol. 26 Issue 3, p191-195. 5p.

Is calcium or cyclic AMP involved in the inhibitory effect on pituitary hormone secretion of the tripeptide aldehyde proteinase inhibitors?

Autor: Makara GB, Szentendrei T, Rappay G

Publikováno v: Molecular and cellular endocrinology [Mol Cell Endocrinol] 1987 Jul; Vol. 52 (1-2), pp. 63-9.